CN105327316A - 垂体前叶机能减退症的治疗药物 - Google Patents
垂体前叶机能减退症的治疗药物 Download PDFInfo
- Publication number
- CN105327316A CN105327316A CN201510839393.XA CN201510839393A CN105327316A CN 105327316 A CN105327316 A CN 105327316A CN 201510839393 A CN201510839393 A CN 201510839393A CN 105327316 A CN105327316 A CN 105327316A
- Authority
- CN
- China
- Prior art keywords
- parts
- hypopituitarism
- anterior
- blood
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 32
- 206010021067 Hypopituitarism Diseases 0.000 title claims abstract description 22
- 241000005787 Cistanche Species 0.000 claims abstract description 5
- 239000010231 banlangen Substances 0.000 claims abstract description 5
- 241001629511 Litchi Species 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 21
- 239000008280 blood Substances 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 13
- 210000003734 kidney Anatomy 0.000 abstract description 13
- 238000011282 treatment Methods 0.000 abstract description 12
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 8
- 208000026435 phlegm Diseases 0.000 abstract description 8
- 230000007812 deficiency Effects 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 6
- 230000001717 pathogenic effect Effects 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 5
- 230000001568 sexual effect Effects 0.000 abstract description 4
- 210000004291 uterus Anatomy 0.000 abstract description 4
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 241000512259 Ascophyllum nodosum Species 0.000 abstract 1
- 244000189799 Asimina triloba Species 0.000 abstract 1
- 235000006264 Asimina triloba Nutrition 0.000 abstract 1
- 235000009467 Carica papaya Nutrition 0.000 abstract 1
- 241000522190 Desmodium Species 0.000 abstract 1
- 240000005717 Dioscorea alata Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 244000183278 Nephelium litchi Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 244000237330 gutta percha tree Species 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000003014 reinforcing effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 201000010099 disease Diseases 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 6
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 206010062767 Hypophysitis Diseases 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 238000001959 radiotherapy Methods 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000032456 Hemorrhagic Shock Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000007913 Pituitary Neoplasms Diseases 0.000 description 2
- 206010036297 Postpartum hypopituitarism Diseases 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 201000009895 Sheehan syndrome Diseases 0.000 description 2
- 206010049771 Shock haemorrhagic Diseases 0.000 description 2
- 239000003470 adrenal cortex hormone Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 210000002149 gonad Anatomy 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000001817 pituitary effect Effects 0.000 description 2
- 208000010916 pituitary tumor Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000021595 spermatogenesis Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- UUTKICFRNVKFRG-WDSKDSINSA-N (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrolidinyl]methyl]-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSCN1C(=O)[C@H]1NC(=O)CC1 UUTKICFRNVKFRG-WDSKDSINSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010001367 Adrenal insufficiency Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010006179 Breast atrophy Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 208000031973 Conjunctivitis infective Diseases 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 208000034423 Delivery Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000018779 Globus Sensation Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019196 Head injury Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010066364 Hypersexuality Diseases 0.000 description 1
- 208000008017 Hypohidrosis Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 241001582888 Lobus Species 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010028665 Myxoedema Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 206010049760 Pituitary haemorrhage Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 102000003946 Prolactin Human genes 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- 206010036941 Prostatic atrophy Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 102000011923 Thyrotropin Human genes 0.000 description 1
- 108010061174 Thyrotropin Proteins 0.000 description 1
- 102400000336 Thyrotropin-releasing hormone Human genes 0.000 description 1
- 101800004623 Thyrotropin-releasing hormone Proteins 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 201000001028 acute contagious conjunctivitis Diseases 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000489 anti-atherogenic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 201000006488 atrophy of prostate Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
- 229960000452 diethylstilbestrol Drugs 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 208000011318 facial edema Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 238000002657 hormone replacement therapy Methods 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000002267 hypothalamic effect Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000001983 lactogenic effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 201000011475 meningoencephalitis Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000003786 myxedema Diseases 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 208000001213 pituitary apoplexy Diseases 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960000874 thyrotropin Drugs 0.000 description 1
- 230000001748 thyrotropin Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000009677 vaginal delivery Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及垂体前叶机能减退症的治疗药物,医药技术领域,在于解决垂体前叶机能减退症的治疗问题,通过分析垂体前叶机能减退症的病因由于平时营养失衡或房事过度,或精力透支而至肾阳亏虚、气血两虚、元气不足、胞宫清寒,风毒趁虚而入,风生痰扰,免疫力低下,采取以补肾固精、补益气血、祛风化痰的中药结合:肉苁蓉15份、木瓜50份、枸杞子30份、陈皮15份、淮山药12份、荔枝肉12份、黄芩15份、杜仲12份、板兰根15份、熟地15份、金钱草12份、昆布10份、生姜10份、甘草7份。垂体前叶机能减退症的治疗药物应用治疗效果快速显著。
Description
技术领域
本发明涉及垂体前叶机能减退症的治疗药物,主要涉及的以多种中药组合为治疗的药物,属于医药学技术领域。
背景技术
垂体前叶机能减退症,是多种病因所致腺垂体激素分泌不足,继发性腺、甲状腺、肾上腺皮质功能低下所呈现的临床征群。病因:垂体瘤,下丘脑病变,垂体缺血性坏死,蝶鞍区手术放疗和创伤,感染和炎症,糖皮质激素长期治疗,垂体卒中等。由于产后大出血,尤其是伴有长时间的失血性休克,使垂体前叶组织缺氧、变性坏死,继而纤维化,最终导致垂体前叶功能减退的综合征,其发生率占产后出血及失血性休克患者的25%左右。近几年研究显示席汉综合征的发生,并非仅与垂体前叶功能减退有关,有报道部分患者垂体前叶功能有减退征象,其中50%显示垂体后叶功能亦有不同程度的异常。席汉综合征不仅可以发生于阴道分娩者,亦可发生于剖宫产术之后,在现代剖宫产率上升的今天,应引起产科医师的高度重视。
垂体前叶机能减退症症状:1.有原发病因可查:如产后大出血、垂体肿瘤、垂体手术或放射治疗、颅脑外伤、感染或炎症(结核、梅毒、脑膜脑炎)、全身性疾病(白血病、淋巴瘤、脑动脉硬化、营养不良)以及免疫性垂体炎等。2.促性腺激素和泌乳素分泌不足症群:产后无乳,闭经,阴、腋、眉毛脱落、稀疏(男性胡须稀少)、性欲减退、消失,外生殖器萎缩,子宫、乳房萎缩(男性阳萎,睾丸、前列腺萎缩)。3.促甲状腺激素不足症群:少气懒言、表情淡漠、智力减退、动作迟缓、食欲减退、畏寒、少汗、皮肤乾燥、面部虚肿苍黄、甚至出现粘液性水肿等。4.促肾上腺皮质激素不足症群:头晕、虚弱无力、恶心、呕吐、腹痛、腹泻、体重减轻、血压下降、易感染和晕厥甚至休克、昏迷等。5.垂体危象;如有各种应激、感染、手术、外伤、精神刺激、消化道疾病、某些药物(镇静、麻醉剂和降糖药等)均可使原发病加重而诱发危象发生。根据甲状腺、肾上腺皮质、性腺等功能低下的具体情况,垂体前叶机能减退症的治疗分别予以长期的激素替代疗法。1.一般治疗:加强营养,适当运动,补充维生素、钙剂,治疗贫血等。2.药物治疗:(1)肾上腺皮质激素口服可的松或氢化可的松,有水肿者,改用泼尼松或地塞米松。当有感染、发热、创伤、手术时,剂量应适当增加。(2)甲状腺素片一般在服用肾上腺皮质激素几天之后开始服用。(3)性激素可采用人工周期疗法:中年以上者可以不用,青年患者口服己烯雌酚,最后5天加用黄体酮,停药3~7天后如月经来潮,可在出血后5天重复使用。有生育要求者,为促排卵可联合应用HMG或HCG,效果良好。上述西药治疗副作用较大,患者还可结合使用中医中药治疗,效果更好。
发明内容
以中医学观点分析垂体前叶机能减退症,此病因可由多种原因引起,除了产后大出血、放疗、手术等损伤性原因之外,平时营养失衡或房事过度,精力透支而至肾阳亏虚、气血两虚、元气不足、胞宫清寒,风毒趁虚而入,风生痰扰,治疗应以补肾固精、补益气血、祛风化痰的中药结合成为为治疗之药物,必药至病除。
垂体前叶机能减退症的治疗药物是按下面各中药质量份比组合而成:肉苁蓉15份、木瓜50份、枸杞子30份、陈皮15份、淮山药12份、荔枝肉12份、黄芩15份、杜仲12份、板兰根15份、熟地15份、金钱草12份、昆布10份、生姜10份、甘草7份。
下面逐一分垂体前叶机能减退症的治疗药物中各中药的药性功效。肉苁蓉味甘、咸,性温,能补肾阳,益精血,润肠通便;用于肾阳不足、精血虚亏,阳痿或不孕,腰膝酸软,筋骨无力;肠燥便秘;另外,还能增强免疫力,调整内分泌促进代谢,促进生长发育;降低血压、抗动脉粥样硬化作用。木瓜有促进腺体分泌、催精催乳的功效,特别是促进乳腺分泌奶液更是效果明显,民间常用食用作妇女产后催奶之药膳食品。枸杞子可调节机体免疫功能、能有效抑制肿瘤生长和细胞突变、具有延缓衰老、抗脂肪肝、调节血脂和血糖、促进造血功能等方面的作用,并应用于临床。陈皮温;辛、苦;归脾、肺经;具有健脾和胃,行气宽中,降逆化痰的功效;主治脾胃气滞,脘腹长满,恶心呕吐,食欲不振,咳嗽痰多,胸膈满闷,梅核气。淮山的功效与作用:淮山具有健脾、补肺、固肾、益精等多种功效;可以降血脂、调理肠胃。荔枝肉味甘、甜,入脾、肾经;果肉具有补肾益气、理气补血、生精固精、补气壮阳的功效;荔枝最大的特效是补肾壮阳,增强性欲,增强人的免疫力,实践证明,荔枝肉比元肉的补肾固精功效更为快速强烈。黄芩的功效:有清热燥湿,凉血安胎,解毒功效;主治温热病、上呼吸道感染、肺热咳嗽、湿热黄胆、肺炎、痢疾、咳血、目赤、胎动不安、高血压、痈肿疖疮等症。杜仲补肝肾,强筋骨,安胎,治腰脊酸疼,足膝痿弱,小便余沥,阴下湿痒,胎漏欲堕,胎动不安,高血压。板蓝根有清热解毒、祛风化痰的功效,对感冒、流感、腮腺炎、红眼病、麻疹等常见病,有较好的预防和治疗作用。熟地归肝、肾经;熟地补血,滋阴,生精补髓,保健益寿。金钱草的功效:具有清热解毒,游滋阴凉阴、散瘀消肿,利湿退黄之功效,可用于热淋,沙淋,尿涩作痛,黄疸尿赤,痈肿疔疮,毒蛇咬伤,肝胆结石。昆布性味咸寒,具有软坚散结、消肿利水、润下消痰的功。生姜的功效与作用祛风、解表、和胃、温经止痛;解热、抗菌、消炎、镇静、止吐、抗过敏作用。甘草片为镇咳祛痰药品,作用颇为广泛,在中药汤剂及中成药配伍中,常用其补气益脾、和中缓急、调和诸药之功效。
垂体前叶机能减退症的治疗药物发明的有益效果是:通过分析垂体前叶机能减退症的病因除了产后大出血、放疗、手术等损伤性原因之外,平时营养失衡或房事过度,精力透支而至肾阳亏虚、气血两虚、元气不足、胞宫清寒,风毒趁虚而入,风生痰扰,免疫力低下,治疗应以补肾固精、补益气血、祛风化痰的中药结合成为为治疗之药物,应用治疗效果明显,药至病除。
具体实施方式
下面以一个垂体前叶机能减退症患者服用量作为优选例作为实施例进一步的说明。
垂体前叶机能减退症的治疗药物适合于一个垂体前叶机能减退症患者服用的一个剂量药量是按下面各中药质量组合而成:肉苁蓉15克、木瓜50克、枸杞子30克、陈皮15克、淮山药12克、荔枝肉12克、黄芩15克、杜仲12克、板兰根15克、熟地15克、金钱草12克、昆布10克、生姜10克、甘草7克。使用方法:煎汤服,日服一剂量,服用一剂量即可见效,连服用3~5个剂量后身体各机能均增强,食量大增,可适当减少服用量和频率。
Claims (1)
1.垂体前叶机能减退症的治疗药物,是按下面各中药质量份比组合而成:肉苁蓉15份、木瓜50份、枸杞子30份、陈皮15份、淮山药12份、荔枝肉12份、黄芩15份、杜仲12份、板兰根15份、熟地15份、金钱草12份、昆布10份、生姜10份、甘草7份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510839393.XA CN105327316A (zh) | 2015-11-27 | 2015-11-27 | 垂体前叶机能减退症的治疗药物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510839393.XA CN105327316A (zh) | 2015-11-27 | 2015-11-27 | 垂体前叶机能减退症的治疗药物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105327316A true CN105327316A (zh) | 2016-02-17 |
Family
ID=55278222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510839393.XA Withdrawn CN105327316A (zh) | 2015-11-27 | 2015-11-27 | 垂体前叶机能减退症的治疗药物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105327316A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105943873A (zh) * | 2016-04-29 | 2016-09-21 | 刘瑞英 | 一种用于垂体前叶功能减退症的中药组合物 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102397499A (zh) * | 2010-09-10 | 2012-04-04 | 赵润清 | 一种治疗垂体前叶机能减退症的中药药方的制备方法 |
| CN102451337A (zh) * | 2010-10-27 | 2012-05-16 | 魏巍 | 一种治疗垂体前叶机能减退症的中药药方的制备方法 |
| CN103083509A (zh) * | 2011-10-27 | 2013-05-08 | 路文鹏 | 一种治疗垂体前叶功能减退症的中药药方的制备方法 |
-
2015
- 2015-11-27 CN CN201510839393.XA patent/CN105327316A/zh not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102397499A (zh) * | 2010-09-10 | 2012-04-04 | 赵润清 | 一种治疗垂体前叶机能减退症的中药药方的制备方法 |
| CN102451337A (zh) * | 2010-10-27 | 2012-05-16 | 魏巍 | 一种治疗垂体前叶机能减退症的中药药方的制备方法 |
| CN103083509A (zh) * | 2011-10-27 | 2013-05-08 | 路文鹏 | 一种治疗垂体前叶功能减退症的中药药方的制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 张丽娟: "中医治愈席汉综合征2例浅析", 《中华现代内科学杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105943873A (zh) * | 2016-04-29 | 2016-09-21 | 刘瑞英 | 一种用于垂体前叶功能减退症的中药组合物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1723926A (zh) | 一种中药药酒及其制法 | |
| CN104983818A (zh) | 一种治疗妇科疾病的中药及其制备方法 | |
| CN104922543A (zh) | 一种治疗闭经的药物组合物及其制备方法 | |
| CN101961458A (zh) | 一种治疗股骨头坏死的内服药物 | |
| CN104353019A (zh) | 舒经调脏的中药热敷袋及其制备方法 | |
| CN104740437A (zh) | 一种治疗便秘的中药组合物及其制备方法 | |
| CN104127756A (zh) | 健脾止泻膏 | |
| CN104922281A (zh) | 一种治疗慢传输型便秘贴敷药膏的中药组方及其制备方法 | |
| CN103285211B (zh) | 一种用于治疗病理肥胖的中药颗粒 | |
| CN105232987A (zh) | 一种促进神经外科术后康复的中药 | |
| CN103330837A (zh) | 一种治疗绝经妇女骨质疏松症的中药组合物 | |
| CN103285294B (zh) | 一种用于预防与治疗先兆流产的中药及其制备方法 | |
| CN102366554A (zh) | 一种治疗皮质醇增多症的中药制剂 | |
| CN105327316A (zh) | 垂体前叶机能减退症的治疗药物 | |
| CN105999110A (zh) | 一种用于治疗女性慢性盆腔疼痛的中药冲剂及制备方法 | |
| CN105362682A (zh) | 一种治疗月经过少的外用药物 | |
| CN104666654A (zh) | 一种治疗阴阳两虚型糖尿病的中药组合物及其制备方法 | |
| CN104800610A (zh) | 一种治疗帕金森病的中药制剂及其制备方法 | |
| CN105031505A (zh) | 一种治疗良性前列腺增生肥大的药物及其制备方法 | |
| CN100431595C (zh) | 用于气滞寒凝胃痛的药物组合物及其制备方法和用途 | |
| CN102366510A (zh) | 一种治疗皮质醇增多症的中药 | |
| CN105012682A (zh) | 席汉氏综合征及其治疗药物 | |
| CN105456904A (zh) | 一种补肾固胎饮 | |
| CN105434934A (zh) | 一种用于治疗妇科更年期综合症的中药丸剂及制备方法 | |
| CN104107304A (zh) | 一种治疗白发病的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160217 |